These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27427600)

  • 21. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
    Huang X; Liao W; Xie Z; Chen D; Zhang CY
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bottlebrush-architectured dextran polyprodrug as an acidity-responsive vector for enhanced chemotherapy efficiency.
    Zhang T; Wang Y; Ma X; Hou C; Lv S; Jia D; Lu Y; Xue P; Kang Y; Xu Z
    Biomater Sci; 2020 Jan; 8(1):473-484. PubMed ID: 31755481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of cholesterol-grafted PEGylated peptides with pH-triggered property as novel drug carriers for cancer chemotherapy.
    Zhang CY; Chen Q; Wu WS; Guo XD; Cai CZ; Zhang LJ
    Colloids Surf B Biointerfaces; 2016 Jun; 142():55-64. PubMed ID: 26930034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.
    Cunningham AJ; Robinson M; Banquy X; Leblond J; Zhu XX
    Mol Pharm; 2018 Mar; 15(3):1266-1276. PubMed ID: 29378128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.
    Deng H; Liu J; Zhao X; Zhang Y; Liu J; Xu S; Deng L; Dong A; Zhang J
    Biomacromolecules; 2014 Nov; 15(11):4281-92. PubMed ID: 25325531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphiphilic polycarbonate conjugates of doxorubicin with pH-sensitive hydrazone linker for controlled release.
    Jiang T; Li YM; Lv Y; Cheng YJ; He F; Zhuo RX
    Colloids Surf B Biointerfaces; 2013 Nov; 111():542-8. PubMed ID: 23893028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles.
    Li F; Snow-Davis C; Du C; Bondarev ML; Saulsbury MD; Heyliger SO
    J Vis Exp; 2016 Aug; (114):. PubMed ID: 27584689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, preparation and characterization of pH-responsive prodrug micelles with hydrolyzable anhydride linkages for controlled drug delivery.
    Seetharaman G; Kallar AR; Vijayan VM; Muthu J; Selvam S
    J Colloid Interface Sci; 2017 Apr; 492():61-72. PubMed ID: 28068545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate-conjugated amphiphilic block copolymer micelle for targeted and redox-responsive delivery of doxorubicin.
    Lv Y; Yang B; Li YM; He F; Zhuo RX
    J Biomater Sci Polym Ed; 2018 Jan; 29(1):92-106. PubMed ID: 29090629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
    Cui C; Xue YN; Wu M; Zhang Y; Yu P; Liu L; Zhuo RX; Huang SW
    Biomaterials; 2013 May; 34(15):3858-69. PubMed ID: 23452389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric prodrug microspheres with tumor intracellular microenvironment bioreducible degradation, pH-triggered "off-on" fluorescence and drug release for precise imaging-guided diagnosis and chemotherapy.
    Pei M; Li G; Ma K; Li J; Wang Y; Liu P
    Colloids Surf B Biointerfaces; 2019 May; 177():313-320. PubMed ID: 30771583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading.
    Leonhard V; Alasino RV; Bianco ID; Garro AG; Heredia V; Beltramo DM
    Int J Nanomedicine; 2015; 10():3377-87. PubMed ID: 26005348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction-sensitive micelles with sheddable PEG shells self-assembled from a Y-shaped amphiphilic polymer for intracellular doxorubicine release.
    Cui C; Yu P; Wu M; Zhang Y; Liu L; Wu B; Wang CX; Zhuo RX; Huang SW
    Colloids Surf B Biointerfaces; 2015 May; 129():137-45. PubMed ID: 25843367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
    Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
    Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
    Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
    Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin delivery.
    Xu M; Qian J; Suo A; Wang H; Yong X; Liu X; Liu R
    Carbohydr Polym; 2013 Oct; 98(1):181-8. PubMed ID: 23987334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.